-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.08204.91% Upside
OncoCyte Corporation Frequently Asked Questions
-
What analysts cover OncoCyte Corporation?
OncoCyte Corporation has been rated by research analysts at Needham, Lake Street, Piper Sandler in the past 90 days.